PRPO
Precipio, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.68
+5.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.70x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.39x
- Price / sales
- 1.28x
- Price / cash flow
- 32.02x
Enterprise value
- Enterprise value
- $35.5M
- EV / sales
- 1.29x
- EV / EBITDA
- 59.14x
- EV / EBIT
- -22.95x
- Market cap
- $35.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026